Adeona Pharmaceuticals, Inc. (AEN) Reports Q3 Loss of $0.04

Adeona Pharmaceuticals, Inc. (NYSE: AEN) reported Q3 EPS of ($0.04), versus ($0.03) reported last year. Revenue for the quarter came in at $293.42 thousand, versus $289.9 thousand reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance